ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 513 filers reported holding ASTRAZENECA PLC in Q4 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,372,620,910 | +17.6% | 17,599,960 | +2.2% | 0.42% | +14.4% |
Q1 2024 | $1,166,798,388 | +76.7% | 17,222,116 | +75.6% | 0.37% | +19.4% |
Q4 2023 | $660,400,466 | -13.8% | 9,805,500 | -13.4% | 0.31% | -20.6% |
Q3 2023 | $766,354,675 | -5.4% | 11,316,519 | +0.0% | 0.39% | +1.0% |
Q2 2023 | $809,760,877 | -1.8% | 11,314,250 | -4.8% | 0.38% | -7.0% |
Q1 2023 | $824,704,976 | -6.7% | 11,881,645 | -8.8% | 0.41% | -9.8% |
Q4 2022 | $883,708,524 | -3.9% | 13,034,049 | -22.3% | 0.46% | -8.4% |
Q3 2022 | $919,655,000 | -18.6% | 16,769,787 | -1.9% | 0.50% | -10.5% |
Q2 2022 | $1,129,543,000 | +10.7% | 17,096,147 | +11.2% | 0.56% | +37.3% |
Q1 2022 | $1,020,134,000 | +73.4% | 15,377,355 | +52.3% | 0.41% | +92.5% |
Q4 2021 | $588,151,000 | +2.8% | 10,097,008 | +6.0% | 0.21% | -1.4% |
Q3 2021 | $572,045,000 | +60.0% | 9,524,576 | +59.6% | 0.22% | +56.9% |
Q2 2021 | $357,489,000 | +16.3% | 5,968,119 | -3.5% | 0.14% | +9.6% |
Q1 2021 | $307,364,000 | -3.9% | 6,181,899 | -3.3% | 0.12% | -7.4% |
Q4 2020 | $319,686,000 | -4.8% | 6,394,991 | +4.4% | 0.14% | -17.2% |
Q3 2020 | $335,688,000 | -7.0% | 6,125,701 | -3.3% | 0.16% | -12.4% |
Q2 2020 | $360,981,000 | +39.2% | 6,335,230 | +9.1% | 0.19% | +7.5% |
Q1 2020 | $259,268,000 | -4.0% | 5,805,499 | +7.2% | 0.17% | +21.8% |
Q4 2019 | $270,133,000 | +12.5% | 5,417,840 | +0.6% | 0.14% | +9.2% |
Q3 2019 | $240,126,000 | +23.7% | 5,387,458 | +14.6% | 0.13% | +26.2% |
Q2 2019 | $194,080,000 | +3.9% | 4,701,550 | +1.7% | 0.10% | +3.0% |
Q1 2019 | $186,875,000 | +8.2% | 4,622,156 | +1.7% | 0.10% | -3.8% |
Q4 2018 | $172,664,000 | +22.7% | 4,546,170 | +27.8% | 0.10% | +48.6% |
Q3 2018 | $140,770,000 | +160.0% | 3,557,507 | +130.7% | 0.07% | +150.0% |
Q2 2018 | $54,150,000 | +56.4% | 1,542,292 | +55.8% | 0.03% | +55.6% |
Q1 2018 | $34,627,000 | +0.7% | 990,203 | -0.1% | 0.02% | +12.5% |
Q4 2017 | $34,380,000 | +2.4% | 990,767 | 0.0% | 0.02% | 0.0% |
Q3 2017 | $33,567,000 | -1.0% | 990,767 | -0.3% | 0.02% | -5.9% |
Q2 2017 | $33,891,000 | -16.6% | 994,165 | -23.8% | 0.02% | -19.0% |
Q1 2017 | $40,627,000 | -11.0% | 1,304,647 | -21.9% | 0.02% | -12.5% |
Q4 2016 | $45,634,000 | -19.8% | 1,670,361 | -3.6% | 0.02% | -20.0% |
Q3 2016 | $56,912,000 | -7.1% | 1,731,969 | -14.6% | 0.03% | -9.1% |
Q2 2016 | $61,240,000 | +7.3% | 2,028,482 | +0.1% | 0.03% | +10.0% |
Q1 2016 | $57,058,000 | +57.5% | 2,026,200 | +89.8% | 0.03% | +66.7% |
Q4 2015 | $36,237,000 | +51.0% | 1,067,379 | +41.5% | 0.02% | +50.0% |
Q3 2015 | $23,999,000 | +1538.2% | 754,208 | +3179.7% | 0.01% | +1100.0% |
Q2 2015 | $1,465,000 | -18.4% | 22,996 | -12.4% | 0.00% | 0.0% |
Q1 2015 | $1,796,000 | -86.9% | 26,248 | -86.3% | 0.00% | -83.3% |
Q3 2014 | $13,732,000 | -94.7% | 192,210 | -94.5% | 0.01% | -94.7% |
Q2 2014 | $257,364,000 | +119604.2% | 3,463,390 | +95547.3% | 0.11% | – |
Q4 2013 | $215,000 | – | 3,621 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |